Answers are grounded in this paper and cite their sources.
A-FABP is a key mediator of cerebral ischaemia injury promoting MMP-9-mediated BBB disruption. Inhibition of A-FABP is a potential strategy to improve IS outcome.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: